Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias
Open Access
- 1 March 2010
- journal article
- Published by Elsevier BV
- Vol. 285 (10), 7459-7474
- https://doi.org/10.1074/jbc.m109.094011
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Mutagenic Mapping Suggests a Novel Binding Mode for Selective Agonists of M1 Muscarinic Acetylcholine ReceptorsMolecular Pharmacology, 2008
- A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity: MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGANDPublished by Elsevier BV ,2008
- Novel Selective Allosteric Activator of the M1Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in RatsJournal of Neuroscience, 2008
- Characterization of a CNS penetrant, selective M1muscarinic receptor agonist, 77‐LH‐28‐1British Journal of Pharmacology, 2008
- High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled ReceptorScience, 2007
- Distinct Structural Changes in a G Protein-coupled Receptor Caused by Different Classes of Agonist LigandsPublished by Elsevier BV ,2007
- Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor LigandsJournal of Biological Chemistry, 2007
- Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonistsLife Sciences, 1995
- Biased Probability Monte Carlo Conformational Searches and Electrostatic Calculations for Peptides and ProteinsJournal of Molecular Biology, 1994
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973